Literature DB >> 844905

Evaluation of surface components of Vibrio cholerae as protective immunogens.

E R Eubanks, M N Guentzel, L J Berry.   

Abstract

Surface components of a motile Inaba strain (CA401) were removed from washed cells by low-speed shearing. Flagella contaminated with a vesicular material (designated as crude flagella [CFA1) were obtained by differential centrifugation of the shear fluid. Vesicles were obtained from a nonflagellated mutant by the same procedure. Homogeneous small vesicles were obtained in diminished yield from CsCl gradients of CF preparations. Treatment of CF with sodium deoxycholate removed the vesicular material and flagellar sheaths and yielded naked flagella (NF). The ability of these preparations of passively protect infant mice suckled by CFW mothers that had been immunized at the time of mating was compared, on a dry-weight basis, with commercial vaccine (CV). Eight-day-old mice were challenged orally with more than 1,000 50% lethal doses of either the homologous or a heterologous (Ogawa Ca411) strain. The most effective immunogen was CF, which provided complete protection at 1 microng against both challenges. CF and vesicles provided 50- to 100-fold greater protection than CV against homologous challenge. With heterologous challenge, vesicles were 10-fold more protective than CV, markedly less protective than CF. The NF offered only slightly greater protection than CV against both challenges. Immunoelectrophoresis revealed an antigen in CF distinct from vesicles, cell wall lipopolysaccharide or NF. This antigen is not present in the nonflagellated mutant and is apparently associated with motility,

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844905      PMCID: PMC421400          DOI: 10.1128/iai.15.2.533-538.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

Review 1.  Immunology of cholera.

Authors:  R A Finkelstein
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

2.  Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments.

Authors:  E J Steele; W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

3.  AN ELECTRON MICROSCOPE STUDY OF VIBRIO FLAGELLA.

Authors:  E A FOLLETT; J GORDON
Journal:  J Gen Microbiol       Date:  1963-08

4.  Detection of Australia antigen and antibody by means of radioimmunoassay techniques.

Authors:  J H Walsh; R Yalow; S A Berson
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

5.  Motility as a virulence factor for Vibrio cholerae.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Virulence factors involved in the intraperitoneal infection of adult mice with Vibrio cholerae.

Authors:  E R Eubanks; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

7.  Antibody cross-linking as a factor in immunity to cholera in infant mice.

Authors:  J E Bellamy; J Knop; E J Steele; W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

8.  Use of fluorescent antibody in studies of immunity to cholera in infant mice.

Authors:  M N Guentzel; L H Field; E R Eubanks; L J Berry
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

9.  Immunity to Vibrio cholerae in the mouse. I. Passive protection of newborn mice.

Authors:  D Pitkin; P Actor
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Mechanism of Action of Intestinal Antibody in Experimental Cholera II. Antibody-Mediated Antibacterial Reaction at the Mucosal Surface.

Authors:  R Freter
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

View more
  18 in total

1.  Effective immunity to dental caries: passive transfer to rats to antibodies to Streptococcus mutans elicits protection.

Authors:  S M Michalek; J R McGhee
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

2.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

3.  Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.

Authors:  K Richardson; J B Kaper; M M Levine
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 4.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 5.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

Review 6.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

7.  Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.

Authors:  I G Resnick; C W Ford; G M Shackleford; L J Berry
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  Use of fluorescent antibody in studies of immunity to cholera in infant mice.

Authors:  M N Guentzel; L H Field; E R Eubanks; L J Berry
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

9.  Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane.

Authors:  K Richardson; C D Parker
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.

Authors:  S D Sears; K Richardson; C Young; C D Parker; M M Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.